Ishita Drugs & Indus P/B Ratio
Ishita Drugs & Indus P/B ratio. Ishita Drugs & Indus (ISHITADR) P/B ratio is 1.91 (Moderate), book value per share ₹40.00 vs Healthcare average P/B of 0.01 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see ISHITADR screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
ISHITADR P/B Ratio — Valuation Insights & Book Value Analysis
Ishita Drugs & Indus price-to-book ratio interpretation, valuation status and historical context — current P/B 1.91 (Moderate). Analyse ISHITADR FII DII holdings to track promoter, FII and institutional holdings.
- Trading at premium to sector average PB of 0.01
Ishita Drugs & Indus P/B Ratio Historical Trend
ISHITADR annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View ISHITADR annual price range for the annual high/low range and current price position.
ISHITADR Historical P/B Ratio — Book Value Per Share & Year-End Price
Ishita Drugs & Indus annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 2.0 | ₹40.0 | ₹79.83 | ₹12 | Moderate |
| 2025 | 2.18 | ₹36.67 | ₹80.00 | ₹11 | Moderate |
| 2024 | 2.77 | ₹33.33 | ₹92.43 | ₹10 | Moderate |
| 2023 | 2.4 | ₹30.0 | ₹71.94 | ₹9 | Moderate |
| 2022 | 1.73 | ₹30.0 | ₹51.75 | ₹9 | Moderate |
ISHITADR vs Healthcare Peers — P/B Ratio Comparison
Ishita Drugs & Indus P/B 1.91 vs Healthcare average 0.01, median 0.65 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |